Sirio Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Peiqing Li
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 9.2% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?
Oct 14
The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More
Sep 30Is Sirio Pharma (SZSE:300791) Using Too Much Debt?
Sep 23Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Is Sirio Pharma (SZSE:300791) A Risky Investment?
Jun 12An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued
Apr 24Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Mar 06CEO
Peiqing Li (59 yo)
no data
Tenure
CN¥1,842,800
Compensation
Mr. Peiqing Li has been Chairman of the Board and General Manager at Sirio Pharma Company Limited since April 23, 2015 and serves as its Non-Independent Director.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | no data | CN¥1.84m | 9.21% CN¥ 590.0m | |
| Deputy GM & Director | 9.6yrs | CN¥1.62m | 7.48% CN¥ 479.4m | |
| Director | 9.6yrs | CN¥120.00k | 3.26% CN¥ 208.9m | |
| Director | 9.6yrs | CN¥1.77m | 2.65% CN¥ 170.0m | |
| Independent Director | 3.3yrs | CN¥120.00k | no data | |
| Independent Director | 3.3yrs | CN¥120.00k | no data | |
| Independent Director | 3.3yrs | CN¥120.00k | no data | |
| Non-Employee Supervisor | 3.3yrs | no data | no data | |
| Supervisor | 2.1yrs | no data | no data |
3.3yrs
Average Tenure
54yo
Average Age
Experienced Board: 300791's board of directors are considered experienced (3.3 years average tenure).